Insider Transactions Reported by 18 Insiders of Adicet Bio, Inc.

Symbol
ACET on Nasdaq
Location
Boston, MA

Insiders trading volume in the past year

Adicet Bio, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
ORBIMED ADVISORS LLC 10%+ Owner $4,490,254 +$5,000,000 08 Oct 2025
CARL L. GORDON Director, 10%+ Owner $941,594 21 Aug 2024
Francesco Galimi SVP & Chief Medical Officer $244,322 05 Jun 2024
Aya Jakobovits Director $214,323 21 Aug 2024
Chen Schor President & CEO, Director $175,718 31 Jan 2025
Brian Nicholas Harvey Chief Financial Officer $83,928 31 Jan 2025
Lloyd Klickstein Director $66,225 11 Jun 2025
Don Healey Chief Technology Officer $58,782 31 Jan 2025
Blake Aftab Chief Scientific Officer $51,843 31 Jan 2025
STEVE DUBIN Director $13,847 11 Jun 2025
Andrew Sinclair Director $10,797 11 Jun 2025
Jeffrey Chodakewitz Director $10,797 11 Jun 2025
Michael Kauffman Director $8,437 21 Aug 2024
Bastiano Sanna Director $7,965 14 Aug 2023
Katie Peng Director $7,198 11 Jun 2025
Julia D. Maltzman Chief Medical Officer 31 Jan 2025
Michael Grissinger Director 17 Apr 2025
STEWART ABBOT Former Chief Scientific and Operating Officer 11 Jun 2021

Recent Insider Transactions by Companies or Individuals for Adicet Bio, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.